This week, Mark Marex, CFA, discusses the Nasdaq Biotechnology Index (NBI) and its performance

Between tackling administrative tasks and reviewing information in hefty board books, board meetings may not be as productive as they can be—or should be. At Nasdaq, we tackled this issue head-on by assessing our processes and developing a playbook for best-in-class board meeting agendas. Using a secure board portal, we’ve created a framework that

Board meetings are critical for maintaining the health and growth of the business. Due to the sheer depth and breadth of topics often discussed during these meetings, important details can get lost in the shuffle if the proper preparation isn’t done. Sometimes, board members want to ask preliminary questions or acquire more details, so they underst

Money is evolving, and as more people join the Bitcoin network, the world may see a decline in the use of cash with the wider adoption of cryptocurrencies as legitimate assets.

Look around your room. Chances are that everything has been in a container, on a plane, or inside a truck at some point. The miracle of international trade is a complex beast, a series of arteries feeding goods to each corner of the globe. And most of us know nothing about it.

Shipping and Logistics in a COVID World

Daily energy market commentary provided by Nasdaq Corporate Solutions Advisory Services‘ Energy Team.

Micron is set to report fourth quarter fiscal 2020 earnings results after the closing bell Tuesday.

The global cannabis market is booming: it’s set to reach $146 billion by 2025. There is a rapidly growing demand for cannabinoids, the compounds found in the cannabis plant.

It’s no small secret that overall VC/PE investments are down due to the COVID-19 pandemic. However, one area that has seen a boost in investment is healthtech.